Brazilian Expert Consensus for NTRK Gene Fusion Testing in Solid Tumors

Oncogenic neurotrophic tropomyosin receptor kinase gene fusions occur in less than 1% of common cancers. These mutations have emerged as new biomarkers in cancer genomic profiling with the approval of selective drugs against tropomyosin receptor kinase fusion proteins. Nevertheless, the optimal path...

Descripción completa

Detalles Bibliográficos
Autores principales: Petaccia de Macedo, Mariana, Toledo Nascimento, Ellen Caroline, Soares, Fernando Augusto, Costa Santini, Fernando, D’Almeida Costa, Felipe, Werneck da Cunha, Isabela, Ramella Munhoz, Rodrigo, De Marchi, Pedro, Carnier Jorge, Thiago William, Ramos Moreira Leite, Kátia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504829/
https://www.ncbi.nlm.nih.gov/pubmed/37719804
http://dx.doi.org/10.1177/2632010X231197080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504829/
https://www.ncbi.nlm.nih.gov/pubmed/37719804
http://dx.doi.org/10.1177/2632010X231197080

Ejemplares similares